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Abstract
Objective Substantial physiological changes occur during
pregnancy and lactation, making breast evaluation challeng-
ing in these patients. This article reviews the imaging chal-
lenges of the breast during pregnancy and lactation. The
normal imaging appearance, imaging protocols and the im-
aging features of each commonly encountered benign and
malignant entity with pathological correlation and support-
ing examples is described. An awareness of the imaging
features of the breast during these physiological states and
of various benign and malignant diseases that occur permits
optimal management.
Conclusions Evaluation of the pregnant and lactating
patients who present with a breast problem is challenging.
Although ultrasound may characterise the finding in many
cases, mammography and even MRI may have a role in the
management of these patients.
Teaching points
• To review physiological changes of the breast during
pregnancy and lactation
• To review imaging protocols of the breast during pregnancy
and lactation
• Discuss imaging findings with pathological correlation of
benign and malignant diseases in pregnancy and lactation
• Discuss pathological correlation of imaging findings in
pregnancy and lactation
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Background
Pregnancy-associated breast cancer occurs with a frequency
of one in 3,000–10,000 pregnancies, accounting for 1–3 %
all breast cancers [1]. It is not infrequent for women to
present to their physicians with a breast problem during
pregnancy or within 1 year of delivery. Changes occurring
in the breast during these physiological states make clinical
and radiological evaluation of these patients challenging.
Improving understanding of varied breast problems and
their imaging appearance on multiple modalities is essential
to ensure optimal management of these patients.
In the first and second trimester, there is proliferation and
differentiation of the lobules, alveoli and lactiferous ducts,
the alveolar epithelium becomes secretory. With rising se-
rum prolactin during the third trimester, the milk-producing
cells continue to differentiate and colostrum eventually fills
the alveoli and milk ducts prior to delivery. These prolifer-
ative changes result in bilateral breast enlargement and
increased overall density of the breast tissue on imaging.
Following delivery, the lactogenic effect of prolactin results
in a substantial increase in milk production. All of these
physiological changes directly impact the imaging appear-
ance of the breast on mammography, ultrasound and mag-
netic resonance imaging (MRI) thereby complicating
evaluation of pregnant and/or lactating patients, presenting
with a breast problem.
Imaging protocols and challenges
Radiological evaluation varies depending upon the age of the
woman, her pregnancy and lactational status. Subsequent to a
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clinical history and thorough physical examination, patients
are frequently imaged to determine whether there is an under-
lying abnormality to account for the patient’s symptoms. For
pregnant and lactating women under the age of 30 years,
ultrasound is the initial imaging test of choice given the lack
of radiation exposure. Mammogram could be considered in
these patients if ultrasound is negative or it reveals indetermi-
nate, suspicious or no findings [2]. Lactating women over
30 years of age are typically imaged using both mammogra-
phy and ultrasound. In an effort to reduce the overall breast
density, lactating patients are encouraged to express milk
immediately prior to imaging. In a pregnant patient, mam-
mography should be performed, if ultrasound reveals a suspi-
cious finding or if biopsy of a solid lesion reveals malignancy.
A complete evaluation of a pregnant patient with a lump
should not be delayed until after delivery, because of fear of
radiation.Without shielding the abdomen, the dose to the fetus
from a four-view mammogram is 0.4 mrad, much less than
background, and with shielding, the risk is not significant and
safe to the fetus [3]. Fetal malformations are known to occur at
a dose exceeding 10 rads [3].
The National Comprehensive Cancer Network guidelines
for clinical practice in pregnant patients with breast cancer
or suspected to have breast cancer, states that “mammogra-
phy of the breast with shielding can be safely done” [4, 5].
Normal imaging appearance of the breast in pregnancy
and lactation
The imaging appearance on mammography, ultrasound and
MRI is variable depending upon the duration of pregnancy
and/or lactating state. An overall diffuse increase in breast
density accompanied by breast enlargement is commonly
seen on mammography (Fig. 1a, b). Given increased density
of the breast the sensitivity of mammography is low (30 %
for dense breast compared with 80 % for fatty breast), and
cancer detection may be somewhat difficult [6]. Murphy et
al. [7] evaluated patients with false-negative mammograms
and symptomatic cancer, and found that 78 % of the mam-
mographically occult lesions were in women with heteroge-
neously or extremely dense tissue. The imaging features of
breast cancer on the mammogram are identical to those seen
in non-pregnant women These are spiculated or irregular
masses, pleomorphic linear branching or grouped microcal-
cifications, focal asymmetries and architectural distortion.
Detection is sometimes difficult as the overlying dense
tissue may obscure the findings.
Ultrasound has a better sensitivity in pregnant and lactating
patients, ranging from 86.7 to 100% [8, 9]. On ultrasound, the
breast predominantly appears diffusely hypoechoic during
pregnancy due to enlargement of the non-fatty fibroglandular
component (Fig. 1c), whereas during lactation there is diffuse
hyperechogenicity with prominent ducts and vascularity dur-
ing lactation [1] (Fig. 1d). Typical imaging findings for breast
cancer on ultrasound are hypoechoic to isoechoic irregular
mass with or without associated posterior shadowing; occa-
sionally there may be posterior acoustic enhancement due to
central necrotic components. Colour Doppler helps assess
vascularity of the mass lesion.
There is a limited role for breast MRI during pregnancy
as intravenous gadolinium crosses the placenta. The routine
use of contrast-enhanced MRI in the evaluation of pregnant
patients is not appropriate and is recommended only in
situations where the risk–benefit ratio is clear [10].
Contrast enhanced MRI can be safely performed in lactating
Fig. 1 Normal pregnancy and
lactational change: a 39-year-
old woman, lactating for
3 months. a Note the larger
breast size and increased densi-
ty of parenchyma in spite of
pumping prior to imaging on
right MLO view compared with
b, reduced density of paren-
chyma on mammogram per-
formed prior to pregnancy. c
Pregnancy change: a 38-year-
old woman, 24 weeks pregnant
presents with breast pain. Note
diffuse hypoechogenicity due to
enlargement of non-fatty fibro-
glandular components during
pregnancy. d Increased echoge-
nicity with ductal prominence,
which is typical appearance of a
lactating breast on grey-scale
ultrasound
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women. Background enhancement on MRI refers to normal
enhancement in glandular tissue. The degree of background
enhancement can influence sensitivity of MRI [11–13].
Lactating breast tissue has a uniformly long T2, resulting
in diffuse high signal intensity on T2-weighted MR images.
Normal lactating tissue shows rapid enhancement followed
by an early plateau of enhancement, unlike normal non-
lactating breast tissue, which shows mild and progressive
enhancement [14] (Fig. 2). Breast cancers are visible during
lactation owing to their lower signal intensity on T2-
weighted images and more intense initial contrast enhance-
ment with early washout compared with normal breast tissue
[14] (Fig. 3), though some authors report an overlap of
enhancement characteristics of invasive cancer with that of
the lactating tissue, attributed to increased vascular perme-
ability [15] (Fig. 4).
If breast MR is performed, the ACR practice guidelines
recommend that it is safe for the mother to continue breast-
feeding after receiving gadolinium. If the mother remains
concerned about any potential ill effects, she should be
given the opportunity to make an informed decision as to
whether to continue or temporarily abstain from breast-
feeding after receiving a gadolinium contrast medium. If
the mother so desires, she may abstain from breast-feeding
for 24 h with active expression and discarding of breast milk
from both breasts during that period. In anticipation of this,
Fig. 2 a Normal lactating tissue showing diffuse rapid enhancement
on dynamic contrast enhanced MRI. b Note the bright ducts (black
arrows) on T2- weighted images
Fig. 3 a A 44-year-old woman, 10 months postpartum and lactating.
Note the irregular spiculated mass (white arrows) showing low signal
intensity on T2–weighted images and (b) intense enhancement (white
arrows) on dynamic contrast enhanced mages. This was a biopsy
proven invasive lobular carcinoma with lymphovascular invasion
Fig. 4 a A 36-year-old woman, 12 months postpartum and lactating.
Note the mass (white arrows) showing high signal intensity on T2–
weighted images and (b) increased enhancement (white arrows) on
dynamic contrast-enhanced images, compared with the rest of the
breast tissue. This was a biopsy-proven grade 3, invasive ductal
carcinoma
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she may wish to use a breast pump to obtain milk before the
contrast study to feed the infant during the 24-h period
following the examination [16].
Breast diseases in the pregnant and lactating patient
A wide variety of benign and malignant breast problems
may be encountered in these patients. Due to physiological
changes, the most commonly encountered problems are
lactational change/lobular hyperplasia, lactational adenoma
and lactational calcifications.
Benign entities include galactocele, fibroadenoma, obstructed
milk duct, mastitis with or without abscess, hyperplastic
intramammary and/or axillary lymph nodes, and granulomatous
mastitis. Malignant diseases include pregnancy-associated breast
cancer and metastatic disease.
Benign entities
Lactational changes/lobular hyperplasia and/or lactational
adenoma
Variable ductal and lobular proliferation in the breast tissue
during pregnancy results in lactational changes that are
Fig. 5 Lactational change: a 31-year-old lactating woman, presenting
with lump in the right breast. a Grey-scale ultrasound shows a partially
circumscribed hypoechoic nodule with cystic areas, (b) with internal
vascularity on power Doppler. c Pathology slide at high power (20×)
shows lobular expansion containing increased numbers of acini, many
of which are enlarged and dilated, consistent with lactational change
Fig. 6 Lactating adenoma: a 38-year-old pregnant woman, presenting
with a breast lump. a Grey-scale ultrasound image shows an isoechoic,
circumscribed nodule. b Power Doppler image shows minimal periph-
eral vascularity. Biopsy was performed revealing lactating adenoma. c
Higher-power image (20×) shows epithelial cell enlargement, cytoplas-
mic vacuolisation and a hobnail appearance with protrusion of cells
into the acinar lumen
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detectable on histopathology. When the lactational change
presents as a palpable or radiographically visible mass, the
benign finding is referred to as a lactational adenoma. It is
the most common breast mass during pregnancy [17].
Usually during the third trimester it reduces in size or
regresses spontaneously after delivery. It occasionally recurs
with subsequent pregnancies. Lactational adenomas can
mimic other benign breast tumours such as fibroadenomas,
phyllodes tumour and circumscribed malignancies.
Although these neoplasms are known to grow due to rising
oestrogen levels associated with pregnancy, their aetiology
is somewhat ambiguous as some suggest they represent a
variant of fibroadenoma, tubular adenoma, lobular hyper-
plasia or arise de novo. The consensus is they are tubular
adenomas with lactational changes [18]. Haemorrhage and
infarction occur in approximately 5 % of cases [17]. These
tumours commonly lack a capsule, which may explain the
absence of a discernible margin. On histopathology, both
lactational change and lactational adenoma show lobular
expansion with numerous enlarged and dilated acini sepa-
rated by connective tissue. On ultrasound, lactational
change occasionally is visible as a homogeneous to hetero-
geneous mass (Fig. 5), whereas lactational adenoma most
often reveals a homogeneous circumscribed oval mass with
posterior acoustic enhancement and gentle lobulations
(Fig. 6). In general the features are benign; however, the
mass can mimic malignancy, showing irregular margins and
posterior shadowing, warranting biopsy [19–21].
Mammography most often shows a circumscribed mass
with no associated calcifications. Management varies be-
tween conservative follow-up imaging and/or biopsy, based
on the imaging appearance. As the coexistence of lactating
adenoma and malignancy has been reported [18, 20], close
clinical follow-up in 3–6 months, even in a biopsy-proven
case, is warranted.
Lactational calcifications
Benign calcifications are sometimes seen in lactating
patients undergoing imaging for a breast problem or for
screening. In general, calcifications are not a common mam-
mographic feature of lactational or post-lactational breast.
On mammography, these are usually diffuse or regional,
predominantly punctate calcifications, and could be bilateral
or unilateral (Fig. 7). Rarely, the calcifications may be
grouped, and in those cases, stereotactic biopsy may be
indicated to exclude malignancy (Fig. 7). In a series of case
reports, all cases had bilateral and diffuse distribution with
focal groups, of which some had a linear branching pattern,
some had a casting pattern [22] and some diffuse with
regional distribution [23]. On histology, the calcifications
are seen in both ducts and lobules. The small rounded
microcalcifications in the lobular acini likely reflect the
granular pattern as seen as focal groups, whereas larger
calcifications in dilated ducts correspond to the casting
pattern on mammography[22]. These are possibly related
to milk stasis or apoptosis associated with lactation [24, 25].
Fig. 7 Lactational calcifications. a A 39-year-old lactating woman
with an area of palpable concern in the right breast. A mammogram
of the left breast, MLO view, shows incidental new diffuse micro-
calcifications (black arrows). Similar findings were also appreciated in
the opposite breast. All of these calcifications represent lactational
deposits. b A 38-year-old lactating woman presented with a right breast
lump; incidental focal microcalcifications (black arrows) were seen in
the left breast at 12:00, magnification view in CC and ML view (not
shown here) showed a focal cluster of slightly pleomorphic calcifica-
tions. Stereotactic biopsy was performed, which revealed lactational
calcifications
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Enlargement of axillary breast tissue
The embryonic mammary ridge (milk line) extends from the
axilla to the groin. Incomplete regression of this ridge dur-
ing embryological formation gives rise to ectopic breast
tissue.
Accessory breast tissue occurs in up to 0.2–6 % of the
general population [26]. Ectopic breast tissue is subject to
the same hormonal influences and risk of disease as eutopic
breast tissue. During menses or pregnancy, hormonal stim-
ulation can cause engorgement and discomfort. As a conse-
quence, these patients typically complain of fullness and
discomfort in this area. Ectopic breast tissue can undergo
lactational change during pregnancy, and in the presence of
a nipple-areolar complex it can give rise to lactation [26].
The axilla is the most common site in which accessory
breast tissue can be found [27]. On mammography, ultra-
sound and MRI, accessory breast tissue has the imaging
appearance of normal breast tissue. Primary carcinoma of
ectopic breast tissue has been reported only in a small
number of cases [27].
Obstructed milk duct
Patients typically present with a tender pea-size to wedge-
shaped lump [28], which is related to mechanical obstruc-
tion secondary to a change in infant feeding pattern, or
scarring from previous surgery, or infection [29]. This may
be in the retroareolar region but can occur in any location in
the breast. On ultrasound, the imaging appearance is vari-
able, ranging from a discrete non-compressible mass or duct
(Fig. 8) to a diffuse echogenic area with a hypoechoic rim.
For recurrent blocked ducts, an obstructive lesion should be
excluded. Ultrasound-guided aspiration is rarely performed
as this is typically managed with warm compresses, mas-
sage and frequent milk expression. Direct aspiration could
be performed for symptom relief and diagnosis. If symp-
toms do not resolve this may progress to mastitis [30].
Mastitis
WHO defines mastitis as an inflammatory condition of the
breast which may or may not be accompanied by infection.
Fig. 8 Blocked milk duct: a 35-year-old lactating woman with fluctu-
ant non-tender breast mass. a Grey-scale ultrasound image reveals
linear hypoechoic structure with no vascularity on power Doppler
(not shown here). Findings were consistent with a blocked milk duct.
b A 27-year-old lactating woman, presenting with tender mass in left
axilla. Grey-scale ultrasound reveals a hypoechoic tubular lesion with
no vascularity on power Doppler (not shown here). This was aspirated,
for symptomatic relief to the patient, yielding milky fluid
Fig. 9 a Mastitis: a 29-year-old lactating woman, presenting with
breast pain and erythema. Ultrasound reveals skin thickening and no
discrete abscess consistent with mastitis. Patient’s redness and pain
resolved after treatment with antibiotics. b Breast abscess: a 39-year-
old lactating woman with left breast erythema swelling and fever.
Grey-scale ultrasound shows a multiloculated fluid collection with
debris representing abscess. Aspiration yielded pus, and microbiology
revealed MRSA
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It is most commonly seen during lactation with a reported
incidence of 6.6–33 % [31]. Although various aetiologies
likely exist (milk stasis, blocked ducts, engorgement or phys-
ical injury to the breast), one more common theory is that poor
attachment of the infant to the breast leads to cracking of the
nipple epithelium, creating a retrograde path for bacteria to
enter the breast tissue [32]. Milk stasis provides a medium for
bacterial growth. The most common causative organism of
lactation-related mastitis and abscess is Staphylococcus aure-
us. Patients can present with breast pain, redness, and swelling
and may have flu-like symptoms. Imaging on ultrasound may
reveal skin thickening, areas of decreased parenchymal echo-
genecity or increased fat echogenecity, increased vascularity
on colour Doppler and reactive or enlarged axillary nodes [33]
(Fig. 9a). Because the organism is usually β-lactamase pro-
ducing, penicillinase-resistant antibiotics should be used [33].
Treatment typically entails antibiotics and frequent breast
feeding or breast emptying to limit milk stasis. Treating mas-
titis promptly prevents abscess formation. If the patient’s
symptoms do not resolve within 2 weeks or are recurrent,
mammography may be indicated to exclude an underlying
malignancy.
Breast abscess
Acute bacterial mastitis will either resolve with antibiotic
therapy or evolve into an abscess if treatment is delayed or
inadequate. Approximately 4.8–11% of lactation-related mas-
titis is complicated by breast abscesses [33]. Infection is most
commonly due to S. aureus (with increasing cases of
methicillin-resistant S. aureus MRSA) and Streptococcus.
The patient presents with fever, chills, tenderness and breast
erythema. Imaging with ultrasound can confirm the diagnosis,
provide a means to drain the collection to tailor antibiotic
therapy and can be safely used for regular follow-up of ab-
scess. Ultrasound is the modality of choice and typically
reveals a complex hypoechoic cystic mass of varied shape,
commonly multiloculated with indistinct margins, peripheral
vascularity and posterior acoustic enhancement (Fig. 9b);
however, there should be no vascularity within the fluid
collection [34]. Mammography is performed only if unclear
of diagnosis and may show signs such as mass, distortion,
asymmetric density and skin thickening, which are not spe-
cific to cancer. Presence of suspicious calcifications is more
specific for cancer [35]. Percutaneous drainage combinedwith
Fig. 10 Galactocele: a 35-year-
old lactating woman, presenting
with a palpable lump. a Photo-
graphic magnification of left
lateral mammogram shows a
well-circumscribed lesion with
a fat fluid level on the lateral
projection. This is the classic
appearance of galactocele. b
Grey-scale ultrasound shows a
cystic lesion which, on adjust-
ing the gain, shows a fat/fluid
level diagnostic of galactocele.
c Another patient, a 38-year-old
lactating woman, presenting
with breast pain and palpable
mass. Mammogram showed
dense breast tissue with a par-
tially obscured mass and skin
thickening (not shown here).
Grey-scale ultrasound image
shows heterogeneous ill-
defined mass, which was vas-
cular on power Doppler. Biopsy
was performed. d Microscopic
high-power image (40×), re-
vealing a ruptured galactocele
with cyst contents leaking into
the surrounding tissue, causing
a lipogranulomatous inflamma-
tion and foamy histiocyte
aggregation
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antibiotic therapy provides effective treatment. In some cases
multiples drainages are required [35–37]. Warm compresses
and frequent breast feeding also help to shorten the duration of
symptoms. The presence of mastitis and/or abscess poses no
risk to the breast feeding infant. Cessation of breast-feeding is
necessary only when treatment with an antibiotic contraindi-
cated for the newborn is prescribed (e.g. tetracycline, cipro-
floxacin or chloramphenicol) or if surgical drainage is
performed [35]. Due to overlap of radiological findings in
infection and inflammatory breast cancer, if there is clinical
suspicion, strong family history or atypical course breast
biopsy or skin punch biopsy should be considered.
Galactocele
It is the most common benign breast lesion in lactating
women and can present in the third trimester, after delivery,
or even after cessation of breast feeding. Galactoceles typ-
ically occur as a result of an obstructed duct leading to
distension of proximal lobular segments. Patients most often
present with a tender mass. The imaging appearance of
galactocele is variable, depending on the amount of fat,
protein and water content [38]. On mammography, a mass
with a fat-fluid level on the lateral projection is a diagnostic
sign in the appropriate clinical setting. (Fig. 10a), The
presence of solid, mobile echogenic contents with distal
acoustic shadowing in a fluid-filled cavity on ultrasound,
is considered to be highly suggestive of a galactocele [39].
On ultrasound, most lesions appear benign with thin, well-
circumscribed margins; the internal appearance may be ho-
mogeneous with low level echoes or heterogeneous,
Fig. 11 Fibroadenoma: a 22-year-old pregnant woman, presenting
with a lump. a Grey-scale ultrasound shows a partially circumscribed
macrolobulated nodule without internal vascularity. Core-needle biop-
sy was performed. b Microscopic low power (10×) reveals a fibroade-
noma, illustrating benign proliferation of glands and stroma
Fig. 12 a Benign reactive lymph node: a 30-year-old pregnant wom-
an, presenting with a palpable lump. Grey-scale ultrasound image
shows well circumscribed hypoechoic nodule, with significant vascu-
larity on power Doppler. b Fine-needle aspiration cytology reveals
polymorphous population of lymphocytes and macrophages, all fea-
tures of benign reactive lymph node. c Metastatic lymph node: a 39-
year-old woman, 12 weeks pregnant, presenting with palpable axillary
mass. The patient had a remote history of breast cancer treated with
mastectomy. Gray-scale ultrasound showed an enlarged axillary node
with abnormally thickened cortex. Core biopsy revealed metastatic
breast cancer
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depending on its contents. It may appear multicystic or have
a complex echotexture (Fig. 10b, c). The margins vary from
well-defined to ill-defined, depending upon the amount of
surrounding inflammation. Histopathology reveals cuboidal
and flat epithelial-lined cysts often accompanied by inflam-
matory and/or necrotic debris (Fig. 10d). If asymptomatic,
or if typical with a fat-fluid level, galactoceles can be man-
aged conservatively.
Fibroadenoma
It is the most common benign breast tumour in young women.
Women typically present with a firm mobile mass. These
tumours are hormone sensitive; hence they often enlarge
during pregnancy and/or lactation in response to elevated
circulating hormones. If during pregnancy the fibroadenoma
outgrows its blood supply, it may undergo infarction, in which
case patients may present with a painful mass. On mammog-
raphy, fibroadenomas appear well circumscribed, have a
round or oval shape and may be smoothly lobulated
(Fig. 11). Coarse popcorn-like calcifications may be seen if
the tumour underwent infarction; otherwise, calcifications are
quite rare as patients tend to be young in age. On ultrasound,
the typical features of a fibroadenomas is round or oval shape,
may show homogeneous internal echoes, well-circumscribed
margins, pseudo-capsule, absence of posterior acoustic shad-
owing and normal adjacent breast tissue [40]. However, dur-
ing pregnancy, the appearance can be somewhat atypical with
cystic changes, increased vascularity and/or prominent ducts.
The presence of atypical features such as microlobulations,
irregular margins, heterogeneous echotexture, posterior
acoustic shadowing and extensive hypoechogenicity, should
lead to percutaneous core biopsy to confirm the diagnosis.
Enlarged intramammary and/or axillary lymph nodes
Benign lymph nodes are usually bilateral multiple, have a
lucent centre and a hilar notch [41]. Benign aetiologies
include regional inflammatory process, infectious diseases,
rheumatoid arthritis and malignant aetiologies include meta-
static breast cancer and lymphoma [41]. During lactation,
enlarged intramammary and/or axillary lymph nodes may be
seen. The hyperplastic nodes are felt to be related to the
bacterial seeding of the nipple by the infant during breast
feeding. These nodes are typically seen in the upper outer
quadrant of the breast and axilla. On mammography, normal
nodes appear oval or bean-shaped with circumscribed some-
times lobulated margins and a radiolucent notch and abnor-
mal nodes are dense [42]. When the lymph nodes are more
than 33 mm, have ill-defined or spiculated margins, or
contain intranodal microcalcifications they are strongly as-
sociated with malignancy [42]. On ultrasound, benign nodes
demonstrate a hypoechoic rim with an echogenic hilum.
Typically, hyperplastic nodes commonly demonstrate con-
centric cortical thickening, whereas asymmetric focal hypo-
echoic cortical lobulations or a completely hypoechoic node
with loss of fatty hilum raises suspicion of malignancy and a
Fig. 13 Granulomatous
mastitis: a 30-year-old woman,
postpartum, presenting with er-
ythema, skin thickening and
draining sinus. Grey-scale ul-
trasound image (a, b) showed
irregular hypoechoic mass with
peripheral vascularity. Biopsy
was performed; high power
image (40×) (c) showed non-
necrotising granulomas, lym-
phocytes and plasma cells in the
background. Special stains for
fungus and mycobacterium
were negative. Follow-up after
conservative treatment and ste-
roids were done. The follow-up
ultrasound image (d) revealed
significant improvement. Find-
ings were consistent with gran-
ulomatous mastitis
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fine-needle aspiration/core biopsy is recommended [43]
(Fig. 12).
Granulomatous mastitis
Granulomatous mastitis is a rare inflammatory disease of
unknown aetiology that often mimics malignancy. It typi-
cally affects young women usually within 6 years of preg-
nancy. Patients may present with a distinct, firm, painful
mass that tends to spare the subareolar regions [1]. Axillary
lymphadenopathy and, rarely, sinus tracts may be encoun-
tered. Inflammatory factors are suggested as possible
causes, although a recent study isolated Corynebacterium
in 75 % of cases [44, 45]. Diagnosis is based on exclusion.
Histology usually reveals non-caseating, granulomatous in-
flammatory reaction and diagnoses such as tuberculosis,
other fungal infections, sarcoidosis, Wegener’s granuloma-
tosis and granulomatous reactions found in association with
carcinomas must be excluded. The imaging appearance can
be variable and at times mimic malignancy. On mammog-
raphy no abnormality may be detected or non-specific im-
aging findings such as a benign-appearing solitary or
multiples mass, architectural distortion, focal asymmetry,
spiculated mass and skin thickening may be seen. Dursun
et al. [46] reported no calcifications in the 36 patients from
their study. On ultrasound, solitary or multiple circum-
scribed heterogeneous hypoechoic masses with tubular con-
figuration, diffuse abscess and fistula formation may be seen
(Fig. 13). MRI is non-specific and may reveal enhancing
mass or non-mass-like enhancement, though one study
showed rim enhancement, and benign time–signal intensity
curve in 22 of 34 patients [46]. Management is challenging,
Fig. 14 Pregnancy-associated
breast cancer: a 36-year-old
woman, 19 weeks pregnant,
presenting with a palpable
lump. Mammogram (a, b)
reveals a dense partially cir-
cumscribed mass in the upper
outer quadrant with associated
microcalcifications. c Grey-
scale ultrasound shows a hypo-
echoic ill-defined mass with
hyperechoic foci of microcalci-
fications. d Power Doppler
shows internal vascularity. e
Microscopic high-power image
(40×) shows grade 3 invasive
ductal carcinoma with lack of
tubule formation, pleomorphic
nuclei and abundant mitotic
figures
536 Insights Imaging (2013) 4:527–538
but usually entails a combination of steroids and wide
surgical excision, particularly for resistant or recurrent dis-
ease [12]. Recurrence is not uncommon.
Malignant entities
Pregnancy-Associated Breast Cancer (PABC)
Breast cancer diagnosed during pregnancy or within the first
year after delivery is referred to as pregnancy-associated breast
cancer. It accounts for 1–2 % of all newly diagnosed breast
cancers each year and affects one out of every 3,000 live births.
Typically presenting as a painless palpable lump, diagnosis is
often delayed as physical examination of the pregnant and
lactating breast is challenging. Overall, PABC is biologically
aggressive with the majority of these tumours being oestrogen
and progesterone receptor negative and Her2-neu receptor
positive. The biological nature of these tumours consequently
bodes a poorer prognosis. During pregnancy, ultrasound
remains the optimal tool for imaging. However, if a suspicious
finding is seen on the ultrasound in a pregnant patient, mam-
mography should be performed. Imaging findings on both
mammography and ultrasound of PABC is identical to cancer
presenting in a non-pregnant or non-lactating woman.
Ultrasound may reveal a circumscribed to spiculated hypoe-
choic to complex mass with irregular shape, posterior shadow-
ing and non-parallel orientation (Fig. 14). Though cancers
usually show posterior acoustic shadowing, in one study of
22 cases, posterior acoustic enhancement was seen in 12 of the
22 patients, likely reflecting the necrotic/cystic degeneration
seen in these aggressive tumours [8]. Other associated findings
include thickening of the Cooper’s ligaments, oedema, skin
thickening and axillary lymphadenopathy. Mammography per-
mits evaluation of microcalcifications, multifocality and multi-
centricity. Typically, a mass with or without associated
pleomorphic calcifications is seen (Fig. 14). Secondary find-
ings might include architectural distortion, nipple or skin re-
traction and lymphadenopathy. MRI is not typically done in
pregnant patients, but can be safely performed in lactating
patients. MRI is done for staging and to evaluate extent of
disease.MRImay reveal a circumscribed to irregular mass with
type II or type III enhancement kinetics. Other findings include
non-mass-like enhancement and ductal enhancement [10].
Metastatic disease
With a reported incidence of 1.7–6.6 %, metastasis to the
breast most commonly occurs from the contralateral breast
cancer, lymphoma/leukaemia, melanoma and lung carcino-
ma. Though, any tumour can metastasise to the breast, non-
mammary metastatic lesions are rare. Imaging entails tar-
geted ultrasound and diagnostic mammography. Most
metastases appear as well-circumscribed masses which lack
calcifications, although psammomatous calcifications may be
seen if the primary is of ovarian or thyroid origin. Metastatic
lesions are more likely multiple and bilateral and are often
found in the subcutaneous fat, whereas primary breast cancers
develop in glandular tissue. Percutaneous core biopsy permits
diagnosis when clinically needed to guide management.
Conclusion
Substantial physiological changes during pregnancy and lac-
tation make it challenging to evaluate patients presenting with
a breast problem. Most findings in pregnant and lactating
patients are benign. Ultrasound is the first-line imaging mo-
dality for all pregnant women and for lactating women less
than 30 years of age. Mammography is indicated in lactating
women over 30 years of age and in pregnant women with
suspicious findings on the initial ultrasound or with a biopsy
diagnosis of breast cancer. An awareness of the imaging
features of the various benign and malignant diseases during
these physiological states, permits optimal management.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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